Page 2 GAO-22-104724 HHS’s COVID-19 Public Education Campaign
2020.
4
Following an internal HHS review, FDA terminated the Atlas
Research contract in November 2020, while Fors Marsh Group has
continued to work on the public education campaign.
The CARES Act includes a provision for us to report on the federal
response to the COVID-19 pandemic. Specifically, the act requires us to
monitor and oversee the federal government’s efforts to prepare for,
respond to, and recover from the pandemic.
5
We also received a request
to conduct a review of HHS’s COVID-19 public education campaign,
including its source of funding. This report is part of our body of work in
response to the CARES Act.
6
In this report, we describe:
1. ASPA, FDA, and NIH’s roles in executing the COVID-19 public
education campaign;
2. ASPA’s efforts to ensure that the Fors Marsh Group campaign
materials aligned with public health recommendations; and
3. how ASPA funded the COVID-19 public education campaign.
To address the first objective, we reviewed documents comprising the
contract files for the two COVID-19 public education campaign awards to
Atlas Research and Fors Marsh Group. Specifically, we reviewed the
interagency agreements between ASPA and CDC, ASPA and FDA, and
ASPA and NIH, as well as the requests for proposals (RFP), submissions
from bidding firms, and documentation of the selection criteria and rating
process. We also reviewed products and deliverables from Atlas
Research and Fors Marsh Group, including, for example, PSAs and
4
See, Hearing entitled Review of Coronavirus Response Efforts, Subcommittee on Labor,
Health and Human Services, Education, and Related Agencies, Committee on
Appropriations, U.S. Senate, September 16, 2020, webcast available online:
https://www.appropriations.senate.gov/hearings/review-of-coronavirus-response-efforts.
Also see, Letters to the Honorable Alex M. Azar II Secretary, Department of Health and
Human Services (Sept. 10 and Oct. 28, 2020), Committee on Oversight Reform, Select
Subcommittee on the Coronavirus Crisis, and Subcommittee on Economic Consumer
Policy, U.S. House of Representatives, available online: https://oversight.house.gov/letters
(accessed 1/6/2022).
5
Pub. L. No. 116-136, § 19010, 134 Stat. 281, 579-81 (2020).
6
We have regularly issued government-wide reports on the federal response to the
COVID-19 pandemic. For the latest report, see GAO, COVID-19: Significant
Improvements Are Needed for Overseeing Relief Funds and Leading Responses to Public
Health Emergencies, GAO-22-105291 (Washington, D.C.: January 2022). Our next
government-wide report will be issued in April 2022 and will be available on GAO’s
website at https://www.gao.gov/coronavirus.